Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Gains from Investment Securities (2022 - 2025)

Neuraxis' Gains from Investment Securities history spans 4 years, with the latest figure at $1.3 million for Q3 2025.

  • For Q3 2025, Gains from Investment Securities rose 19516.32% year-over-year to $1.3 million; the TTM value through Sep 2025 reached $1.3 million, up 325.76%, while the annual FY2024 figure was $1.3 million, 0.0% changed from the prior year.
  • Gains from Investment Securities for Q3 2025 was $1.3 million at Neuraxis, roughly flat from $1.3 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $1.3 million in Q4 2022 and bottomed at -$592853.0 in Q3 2023.
  • The 4-year median for Gains from Investment Securities is $63339.0 (2022), against an average of $477508.3.
  • The largest annual shift saw Gains from Investment Securities tumbled 754.16% in 2023 before it skyrocketed 19516.32% in 2025.
  • A 4-year view of Gains from Investment Securities shows it stood at $1.3 million in 2022, then changed by 0.0% to $1.3 million in 2023, then changed by 0.0% to $1.3 million in 2024, then changed by 0.0% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for NRXS's Gains from Investment Securities are $1.3 million (Q3 2025), $1.3 million (Q2 2025), and $842214.0 (Q1 2025).